Skip to main content
. 2025 May 17;25:713. doi: 10.1186/s12879-025-11071-6

Table 2.

Demographics and clinical characteristics of RSV patients

Characteristics Total (N) n %(n/N), CI P-Value
Total 212 11 5.19(2.61, 9.09)
Gender
 Male 117 5 4.27 (1.40, 9.69) 0.505
 Female 95 6 6.31 (2.35, 13.24)
Age in years
 50- 64 96 3 3.13 (0.64, 8.86) 0.627
 65- 79 83 6 7.23 (2.69, 15.07)
  ≥ 80 33 2 6.45 (0.79, 21.42)
Hospitalization
 Out-patient 158 7 4.43 (1.79, 8.91) 0.394
 In-Patient 54 4 7.41 (2.05, 17.89)
Ventilator Usage
 Yes 26 2 7.69 (0.94, 25.13) 0.808
 No 186 9 4.86 (2.24, 9.03)
Patient diagnosis
 Acute Resp. Infect 121 5 4.13 (1.35, 9.37 0.684
 Pneumonia 65 3 5.88 (1.22, 16.24)
 Bronchitis 2 0 0
 ARI unspecified 24 3 7.50 (1.57, 20.38)
Chronic illnesses
 Asthma 5 0 0 0.447
 Hypertension 2 0 0
 CHF 6 1 16.67 (0.43, 64.12)
 Diabetes 6 1 16.67 (0.43, 64.12)
Symptoms
 Fever (> 37.5) 10 1 4.95 (2.39, 8.91) 0.482
 Breathing Difficulty 78 6 7.69 (2.87, 15.99) 0.21
 Cough 121 10 8.85 (4.32, 15.67) 0.023
 Wheezing 3 0 0 0.683

N Number of study participants, n Number of RSV positive patients, CI Confidence interval